Inventor · disambiguated record
Katja Fink
Also filed as: FINK KATJA
9 granted patents·8 pending applications·29 citations·filing 2012–2023
84Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD6VIR BIOTECHNOLOGY INC5AGENCY SCIENCE TECH & RES3HUMABS BIOMED SA1IMMUNOSCAPE PTE LTD1
Top patents by PatentIndex Score
17 records- 0194US11168128B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Nov 9, 2021·12 cites·30 claims
- 0293US10604561B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Mar 31, 2020·11 cites·15 claims
- 0392US12187786B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Jan 7, 2025·1 cites·1 claims
- 0491US11479599B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Oct 25, 2022·2 cites·30 claims
- 0584US10844113B2Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 24, 2020·2 cites·11 claims
- 0672US11780908B2Anti-dengue virus antibodies, polypeptides containing variant FC regions, and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·6 claims
- 0771US2023331821A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 0871US2024190948A1Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0968US11499157B2Immunomodulatory small hairpin RNA moleculesUNIV NANYANG TECH·Filed 2019·Granted Nov 15, 2022·1 cites·18 claims
- 1060US11891432B2Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 6, 2024·0 cites·2 claims
- 1155US2025262242A1Human t cell receptors specific for antigenic peptides derived from mitogen-activated protein kinase 8 interacting protein 2 (mapk8ip2), epstein-barr virus or human endogenous retrovirus, and uses thereofIMMUNOSCAPE PTE LTD·Filed 2023·Application pending·0 cites
- 1251US2025263466A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1350US2024059757A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1448US2023084102A1Antibodies binding to plasmodium circumsporozoite protein and uses thereofHUMABS BIOMED SA·Filed 2020·Application pending·0 cites
- 1546US2015231226A1Novel attenuated dengue virus strains for vaccine applicationAGENCY SCIENCE TECH & RES·Filed 2013·Application pending·0 cites
- 1644US2014349321A1Binding molecules against dengue virus and uses thereofAGENCY SCIENCE TECH & RES·Filed 2012·Application pending·0 cites
- 1738US10316078B2Serotype cross-reactive, dengue neutralizing antibody and uses thereofAGENCY SCIENCE TECH & RES·Filed 2016·Granted Jun 11, 2019·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Katja Fink files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →